Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Respiratory tract diseases

Proton pump inhibitors linked to pneumonia risk beyond first year of use

Research into long-term proton pump inhibitor use among older adults has led to cautions over pneumonia risk.

Long-term proton pump inhibitor (PPI) therapy in older adults is associated with an increased risk of pneumonia, research has shown[1].

Researchers studied data from England on 75,050 people aged 60 years and over who received a PPI for a year or longer and compared them with an equal number of matched controls.

The team found that the risk of pneumonia in the second year after initiating PPI treatment was 82% greater than among controls. Estimates were similar across age and comorbidity subgroups.

“Our findings support the need for caution in long-term prescribing of PPIs to older adults,” said the researchers in the Journal of the American Geriatric Society (20 April 2018).

“Further work is needed to clarify indication biases in PPI prescribing, especially in older adults hospitalised for pneumonia,” they concluded.

PPIs have been linked to an increased risk of pneumonia in older adults but most research has only looked at the period up to 30 days from treatment initiation.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20204973

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Pharmacy Registration Assessment Questions 2

    Pharmacy Registration Assessment Questions 2

    Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.

    £35.00Buy now
  • Principles of Good Clinical Practice

    Principles of Good Clinical Practice

    A one-stop source for the proper conduct of clinical trials. Essential information on clinical trial design and pharmacovigilance.

    £49.00Buy now
  • Remington Education: Drug Information and Literature Evaluation

    Remington Education: Drug Information and Literature Evaluation

    Remington Education: Drug Information & Literature Evaluation teaches students how to effectively and efficiently locate and analyze up-to-date drug information and literature.

    £27.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • X-ray of a patient's lungs with pneumonia

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.